Publicaciones (105) Publicaciones de JAVIER RODRIGUEZ CARRIO

2024

  1. Coronary Ectasia and Antinuclear Antibodies: Another Clue to the Role of Immunology in Vascular Disease

    American Journal of Cardiology

  2. Immunology and atherosclerosis: is there an individual ID which defines our susceptibility?

    European heart journal

  3. Targeting Inflammation and Immunology: A Hope for the Frequent Flyers?

    JACC: Cardiovascular Interventions

  4. The management of cardiovascular risk in psoriatic disease: A bridge over troubled water

    Seminars in Arthritis and Rheumatism, Vol. 65

  5. Type I interferon pathway activation across the antiphospholipid syndrome spectrum: associations with disease subsets and systemic antiphospholipid syndrome presentation

    Frontiers in Immunology, Vol. 15

2023

  1. 2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases

    Annals of the Rheumatic Diseases, Vol. 82, Núm. 1, pp. 48-56

  2. 2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice

    Annals of the Rheumatic Diseases, Vol. 82, Núm. 6, pp. 754-762

  3. Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider

    RMD Open, Vol. 9, Núm. 1

  4. Association of gamma glutamyl transferase in the presence and progression of abdominal aortic calcifications and changes to bone mineral density

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 15, Núm. 3, pp. 93-99

  5. Association of vocational interventions and work-related factors with disease and work outcomes in people with RMDs: A systematic review

    Seminars in Arthritis and Rheumatism, Vol. 58

  6. Cardiovascular Risk Factors and Events in Fibromyalgia Patients

    The Israel Medical Association journal : IMAJ, Vol. 25, Núm. 9, pp. 627-630

  7. Comment: Humoral responses against HDL are linked to lipoprotein traits, atherosclerosis and pathogenic pathways during early arthritis stages: Reply

    Rheumatology (Oxford, England), Vol. 62, Núm. 10, pp. e301-e302

  8. Developing a framework for the implementation of recommendations for lifestyle factors for people with RMDs across Europe: assessment of current materials and implementation needs

    RMD open, Vol. 9, Núm. 3

  9. Diagnosis and management of cardiovascular risk in rheumatoid arthritis: main challenges and research agenda

    Expert Review of Clinical Immunology, Vol. 19, Núm. 3, pp. 279-292

  10. Editorial: Global excellence in rheumatology: Europe

    Frontiers in Medicine

  11. Humoral responses against HDL are linked to lipoprotein traits, atherosclerosis, inflammation and pathogenic pathways during early arthritis stages

    Rheumatology (Oxford, England), Vol. 62, Núm. 8, pp. 2898-2907

  12. In-stent restenosis is associated with proliferative skin healing and specific immune and endothelial cell profiles: results from the RACHEL trial

    Frontiers in Immunology, Vol. 14

  13. Metabolic Syndrome and Its Components Have a Different Presentation and Impact as Cardiovascular Risk Factors in Psoriatic and Rheumatoid Arthritis

    Journal of Clinical Medicine, Vol. 12, Núm. 15

  14. The three W’s of type I interferons in rheumatic and musculoskeletal diseases: why, what and who?

    ARP Rheumatology

  15. Transcriptomic clustering of critically ill COVID-19 patients

    The European respiratory journal, Vol. 61, Núm. 1